Indivior Pharmaceuticals (INDV) Research & Development (2022 - 2025)
Historic Research & Development for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $33.0 million.
- Indivior Pharmaceuticals' Research & Development rose 5000.0% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 1739.13%. This contributed to the annual value of $107.0 million for FY2024, which is 775.86% down from last year.
- Per Indivior Pharmaceuticals' latest filing, its Research & Development stood at $33.0 million for Q3 2025, which was up 5000.0% from $21.0 million recorded in Q2 2025.
- Indivior Pharmaceuticals' Research & Development's 5-year high stood at $33.0 million during Q3 2025, with a 5-year trough of -$38.0 million in Q4 2024.
- For the 4-year period, Indivior Pharmaceuticals' Research & Development averaged around -$4.0 million, with its median value being -$16.0 million (2022).
- In the last 5 years, Indivior Pharmaceuticals' Research & Development tumbled by 12857.14% in 2023 and then surged by 22222.22% in 2024.
- Quarter analysis of 4 years shows Indivior Pharmaceuticals' Research & Development stood at -$29.0 million in 2022, then dropped by 3.45% to -$30.0 million in 2023, then fell by 26.67% to -$38.0 million in 2024, then soared by 186.84% to $33.0 million in 2025.
- Its last three reported values are $33.0 million in Q3 2025, $21.0 million for Q2 2025, and $22.0 million during Q1 2025.